BTK is expressed in human cardiac tissue and appears to be expressed greater in patients with atrial fibrillation compared to those in normal sinus rhythm [16, 17], which could explain the pro-arrhythmogenic effects of ibrutinib in atrial dysrhythmias. Here, BTK is linked to atrial fibrillation.